← Back to Search

Advance Care Planning for Advance Care Planning

N/A
Waitlist Available
Led By R T Goins, PhD
Research Sponsored by Western Carolina University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; cohort 2: baseline, 2nd pretest 6 months after baseline, 8 weeks after 2nd pretest
Awards & highlights

Study Summary

This trial will create a culturally-tailored version of an end-of-life care program, assess its feasibility, and examine if it leads to increased self-efficacy, readiness, and completion of end-of-life care plans.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; cohort 2: baseline, 2nd pretest 6 months after baseline , 8 weeks after 2nd pretest
This trial's timeline: 3 weeks for screening, Varies for treatment, and cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; cohort 2: baseline, 2nd pretest 6 months after baseline , 8 weeks after 2nd pretest for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Advance Care Planning Engagement Survey Score Change
Change in Self-Report of Advance Directive
Secondary outcome measures
Change in Barriers to Advance Care Planning
Cohort 1: baseline, 8 weeks after baseline and 6 months after baseline; Cohort 2: baseline, 2nd pretest 3 months after baseline , 8 weeks after 2nd pretest

Trial Design

2Treatment groups
Experimental Treatment
Group I: Advance Care Planning WaitlistExperimental Treatment1 Intervention
Waitlist Group- Baseline control measures will be collected at the same time as Cohort 1 completes their pretest. Six Months after Cohort 1, participants will be pretested again before attending a Community Information Session on advance care planning and an one-on-one Sharing Session about Advance Care Planning.
Group II: Advance Care Planning ExperimentalExperimental Treatment1 Intervention
Community Information Session on advance care planning and private one-on-one Sharing Session about advance care planning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Advance Care Planning
2022
N/A
~200

Find a Location

Who is running the clinical trial?

Western Carolina UniversityLead Sponsor
4 Previous Clinical Trials
124 Total Patients Enrolled
Pacific Institute for Research and EvaluationOTHER
26 Previous Clinical Trials
34,059 Total Patients Enrolled
R T Goins, PhDPrincipal InvestigatorWestern Carolina University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~49 spots leftby Apr 2025